Reproductive Factors and Risk of Meningioma and Glioma
Overview
Oncology
Public Health
Authors
Affiliations
Female sex hormones have previously been suggested as possible risk factors for brain tumors, but published studies have reported conflicting results. We conducted a population-based case-control study of glioma (n=626) and meningioma (n=906) cases and randomly selected controls stratified on age and geographic region (n=1,774) in Denmark, Finland, Norway, Sweden, and the United Kingdom. Unconditional logistic regression was used to estimate odds ratios (OR) for glioma and meningioma in relation to reproductive factors. A decreased glioma risk was associated with ever-pregnancy compared with never-pregnancy [OR, 0.8; 95% confidence interval (95% CI), 0.6-1.0]. Meningioma risk among women ages <50 years was increased in relation to number of pregnancies leading to a live birth (OR, 1.8; 95% CI: 1.1-2.8 for giving birth to 3 children compared with nulliparous women; P(trend) among parous women=0.01). This relation was not found for older women. Breast-feeding among parous women increased the glioma risk (OR, 2.2; 95% CI, 1.3-3.9 for breast-feeding 36 months or more compared with breast-feeding 3 months or less). Menopausal status and age at menopause were not associated with meningioma or glioma risk. Our findings imply that reproductive hormones may influence the occurrence of meningioma and glioma.
Gheorghiu A, Brunborg C, Johannesen T, Helseth E, Zwart J, Wiedmann M Front Oncol. 2024; 14:1428142.
PMID: 39188673 PMC: 11345274. DOI: 10.3389/fonc.2024.1428142.
Nguyen P, Roland N, Neumann A, Hoisnard L, Passeri T, Duranteau L Lancet Reg Health Eur. 2024; 42:100928.
PMID: 38800110 PMC: 11127190. DOI: 10.1016/j.lanepe.2024.100928.
Price M, Neff C, Nagarajan N, Kruchko C, Waite K, Cioffi G Neuro Oncol. 2024; 26(Supplement_3):iii1-iii53.
PMID: 38709657 PMC: 11073545. DOI: 10.1093/neuonc/noae047.
Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications.
Caruso G, Ferrarotto R, Curcio A, Metro L, Pasqualetti F, Gaviani P Cancers (Basel). 2023; 15(18).
PMID: 37760490 PMC: 10526192. DOI: 10.3390/cancers15184521.
Wu Y, Xue Y, Wang X, Li J, Qu Y, Zhao T Front Oncol. 2023; 13:1172143.
PMID: 37554166 PMC: 10405728. DOI: 10.3389/fonc.2023.1172143.